ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 15,990
+680 (4.44%)
Mar 12, 2026, 2:15 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 167.87 billion as of March 11, 2026. Its market cap has decreased by -9.03% in one year.
Market Cap
167.87B
Enterprise Value
150.83B
Revenue
5.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,990.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has increased from 160.82B to 167.87B, an increase of 4.38%. That is a compound annual growth rate of 2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 167.87B | -15.43% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 275.82B |
| HLB Therapeutics | 240.12B |
| EASY BIO,Inc. | 228.27B |
| Genexine | 221.03B |
| Vaxcell-Bio Therapeutics | 182.11B |
| Macrogen | 177.58B |
| iNtRON Biotechnology | 167.99B |
| MedPacto | 164.52B |